NCT00063804View on ClinicalTrials.gov

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2006

Conditions
HIV Infections
Interventions
DRUG

Ritonavir

DRUG

AMD070

Trial Locations (2)

21205

Johns Hopkins Adult AIDS CRS, Baltimore

98104

University of Washington AIDS CRS, Seattle

All Listed Sponsors
collaborator

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00063804 - Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men | Biotech Hunter | Biotech Hunter